A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)

Hye Ryun Kim, Joung Soon Jang, Jong Mu Sun, Myung Ju Ahn, Dong Wan Kim, Inkyung Jung, Ki Hyeong Lee, Joo Hang Kim, Dae Ho Lee, Sang We Kim, Byoung Chul Cho

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science